H.C. Wainwright & Co. Sees Significant Upside Ahead For Spectrum Pharmaceuticals
August 08, 2014 at 09:31 AM EDT
In a report published Friday, H.C. Wainwright & Co. analyst Reni Benjamin reiterated a Buy rating and $15.00 price target on Spectrum ...